Chemical Compound
RIP2 kinase inhibitor 1
CAS Registry Number
1423186-80-4
Primary Record
RIP2 kinase inhibitor 1
- In stock
- 9,263 g
- Purity
- 98.2 %
- CAS
- 1423186-80-4
Compound Identifiers & Properties
- CAS
- 1423186-80-4
- PubChem CID
- 71258526
- SMILES
- CC(C)(C)S(=O)(=O)C1=C(C=C2C(=C1)C(=NC=N2)NC3=CC4=C(C=C3)SC=N4)OCCO
- Canonical SMILES
- CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO
Names & Synonyms
- RIP2 kinase inhibitor 1
- GSK2983559 active metabolite
- 1423186-80-4
- RIPK2 inhibitor 1
- RIPK2 inhibitor 5
- CHEMBL4514780
- orb1301820
- GSK2983559
- SCHEMBL14697655
- SCHEMBL29508237
- GTPL10419
- C21H22N4O4S2
- UHDOJINBFLDQJM-UHFFFAOYSA-N
- GSK-2983559 active metabolite
- GSK2983559 active metabolite?
- BCP24219
- EX-A5567
- YGC18680
- BDBM50516677
- MFCD30489727
- AKOS032945042
- ZINC205398491
- 2893X36L7K
- compound 5 [PMID: 31265286]
- CS-5912
- DA-67214
- DA-67221
- HY-19764
- MS-28390
- A16312
- F85445
- A999634
- 2-[4-(1,3-benzothiazol-5-ylamino)-6-tert-butylsulfonylquinazolin-7-yl]oxyethanol
- 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethan-1-ol
- RIP2 kinase inhibitor 1 ;GSK-2983559;GSK 2983559
- 2-[4-(1,3-benzothiazol-5-ylamino)-6-~{tert}-butylsulfonyl-quinazolin-7-yl]oxyethanol
- 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethanol
- 2-[4-(1,3-benzothiazol-5-ylamino)-6-tert-butylsulfonyl-quinazolin-7-yl]oxyethanol
- 1290490-78-6
- 2-{[4-(1,3-BENZOTHIAZOL-5-YLAMINO)-6-(2-METHYLPROPANE-2-SULFONYL)QUINAZOLIN-7-YL]OXY}ETHANOL
- 2380028-10-2
- Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-
- KA2